AlexGalvan

Associate

(T) + 1.404.581.8601

Alex Galvan's practice focuses on complex civil litigation in state and federal courts. He has experience in many aspects of discovery and trial preparation, including taking depositions, motions practice, and witness preparation. He is currently involved in Jones Day's nationwide defense of the Engle progeny smoking and health lawsuits brought against R.J. Reynolds Tobacco Company.

Alex's experience also includes defending a national juvenile products manufacturer in product liability actions across the country, and he has significant experience representing a national fast-food chain in Title VII, FLSA, and other employment law claims.

Alex is actively involved in the Georgia State College of Law mock trial program and serves as one of the program's coaches.

Experience

R.J. Reynolds wins complete defense verdict in Russell wrongful death lawsuit
On January 25, 2019 after a trial lasting 15 days, a jury in Lakeland, Florida returned a complete defense verdict in favor of Jones Day client R.J. Reynolds Tobacco Company in a wrongful death action.

R.J. Reynolds wins complete defense verdict in Hochreiter wrongful death lawsuit
On November 16, 2018, after a trial lasting 11 days, a jury in Orlando, Florida returned a complete defense verdict in favor of Jones Day client R.J. Reynolds Tobacco Company in a wrongful death action.

R.J. Reynolds wins complete defense verdict in Durrance "Engle progeny" trial
On February 8, 2017, Jones Day client R.J. Reynolds Tobacco Company received a complete defense verdict in a wrongful death action.

Additional Publications

Publications Prior to Jones Day

2016
Contributing author, Recent Developments in Toxic Tort & Environmental Law, Tort Trial & Insurance Practice Law Journal, Vol. 51, Issue 2, American Bar Association

2015
Let's Talk About "Sex": Workplace Protections for LGBT Employees under Title VII, Employment Law Landscape

2015
As REITs Expand, Threat of Data Security Breaches Becomes Concern, co-author, National Real Estate Investor

2014
A Second Opinion on Pharmaceutical Reverse Payment Settlements: Why Actavis Missed the Mark, 30 Ga. St. L. Rev. 561

2014
Civil Practice Act HB 366, co-author,Ga. St. L. Rev., Vol. 30, Issue 1, Article 3

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.